Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Orange symbols : Jnj save search
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
VNDA | $4.8 -6.07% -6.46% 2.1M
|
Health Technology
|
| O: 0.27%
H: 20.82%
C: 11.51%
year pharmaceuticals financial results
Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
Published: 2024-01-26 (Crawled : 04:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
VNDA | $4.8 -6.07% -6.46% 2.1M
|
Health Technology
|
| O: 0.79%
H: 1.05%
C: -1.83%
ponvory patent pharmaceuticals
Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.89%
H: 0.0%
C: 0.0%
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
|
| O: 1.19%
H: 3.09%
C: 1.3%
SYK | $327.68 0.69% 0.0% 1.6M
|
Health Technology
|
| O: 0.16%
H: 0.52%
C: -0.64%
MDT | $80.57 1.37% 0.0% 5M
|
Health Technology
|
| O: 1.05%
H: 2.38%
C: 0.81%
PHG | News | $20.61 3.15% 0.05% 1.6M
|
Health Technology
|
| O: 4.96%
H: 1.5%
C: 0.91%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 1.21%
H: 0.27%
C: -0.52%
stroke reach treatment research market
Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
Published: 2023-12-07 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
VNDA | $4.8 -6.07% -6.46% 2.1M
|
Health Technology
|
| O: 6.68%
H: 1.39%
C: -7.89%
ponvory approved sclerosis pharmaceuticals
Body Lotion Market to Reach $85.3 billion, Globally, by 2032 at 4.3% CAGR: Allied Market Research
Published: 2023-12-05 (Crawled : 07:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.09%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
COTY | $11.28 1.17% 0.0% 6.9M
|
Consumer Non-Durables
|
| O: -1.1%
H: 0.77%
C: -1.79%
reach research market
Shoulder Arthroscopy Market to Reach $712.12 Million, globally, by 2032 at 5.1% CAGR: Allied Market Research
Published: 2023-11-22 (Crawled : 06:00) - prnewswire.com
SYK | $327.68 0.69% 0.0% 1.6M
|
Health Technology
|
| O: 0.66%
H: 0.29%
C: -0.52%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
CNMD | $72.61 -0.04% -1.31% 340K
|
Health Technology
|
| O: 1.0%
H: 0.48%
C: -1.31%
CNMD | $72.61 -0.04% 0.0% 340K
|
Health Technology
|
| O: 1.0%
H: 0.48%
C: -1.31%
reach research market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
BMY | $49.14 0.43% 0.0% 7.9M
|
Health Technology
|
| O: 0.69%
H: 0.06%
C: -0.68%
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: 0.5%
H: 0.82%
C: 0.75%
reach research hiv market
Surgical Equipment Market to Reach $59 Billion, Globally, by 2032 at 5.2% CAGR: Allied Market Research
Published: 2023-10-31 (Crawled : 14:00) - prnewswire.com
MDT | $80.57 1.37% 0.0% 5M
|
Health Technology
|
| O: -0.09%
H: 1.49%
C: 0.93%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
CNMD | $72.61 -0.04% -1.31% 340K
|
Health Technology
|
| O: 0.74%
H: 1.39%
C: -0.84%
BSX | $68.02 1.03% 0.0% 7.6M
|
Health Technology
|
| O: 0.7%
H: 2.1%
C: 1.57%
CNMD | $72.61 -0.04% 0.0% 340K
|
Health Technology
|
| O: 0.74%
H: 1.39%
C: -0.84%
reach research market
Advanced Wound Care and Closures Market to Reach $32.9 Billion, Globally, by 2032 at 5.4% CAGR: Allied Market Research
Published: 2023-10-26 (Crawled : 00:00) - prnewswire.com
MDT | $80.57 1.37% 0.0% 5M
|
Health Technology
|
| O: 1.01%
H: 0.48%
C: -2.32%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
BAX | $40.4 2.36% 0.0% 3.2M
|
Health Technology
|
| O: 0.71%
H: 0.26%
C: -1.59%
MMM | $92.62 0.38% 0.15% 3M
|
Producer Manufacturing
|
| O: 0.53%
H: 0.13%
C: -1.8%
IART | $28.96 0.98% 0.97% 1.6M
|
Health Technology
|
| O: 0.45%
H: 0.64%
C: -4.15%
reach care research market
Healthcare Finance Solutions Market to Reach $276.04 billion, Globally, by 2032 at 9.3% CAGR: Allied Market Research
Published: 2023-09-08 (Crawled : 15:30) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 1.47%
H: 0.0%
C: -2.56%
PHG | News | $20.61 3.15% 0.05% 1.6M
|
Health Technology
|
| O: -2.02%
H: 0.62%
C: -0.43%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
CBSH 4 | $54.91 1.97% 1.93% 440K
|
Finance
|
| O: 0.41%
H: 0.79%
C: 0.45%
reach research solutions market
Sunless Tanners Global Market Report 2023: Advanced Formulas and Technologies Boost Growth
Published: 2023-05-26 (Crawled : 23:00) - prnewswire.com
EPC 4 | $36.84 0.52% 0.0% 200K
|
Consumer Non-Durables
| Email alert
Add to watchlist
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
UL | $48.06 1.59% 0.0% 3.1M
|
Consumer Non-Durables
| Email alert
Add to watchlist
UNLYF | $47.6 1.3% 270
|
Consumer Non-Durables
| Email alert
Add to watchlist
report global growth market
Open Book Extracts Announces Allen Olson as VP of Supply Chain
Published: 2023-04-25 (Crawled : 12:20) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.38%
H: 0.63%
C: 0.53%
ERLEADA® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option Now Available in the U.S.
Published: 2023-04-03 (Crawled : 16:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.03%
H: 1.33%
C: 1.23%
erleada
Real-World Study Shows Patients Treated with IMBRUVICA® (ibrutinib) Were Less Likely to Initiate a Next-Line Treatment than Patients on Acalabrutinib in First-line Chronic Lymphocytic Leukemia
Published: 2022-12-12 (Crawled : 17:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 1.09%
C: 1.07%
imbruvica treatment leukemia study
New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA® (ibrutinib) Plus Venetoclax Demonstrate Robust Efficacy and Sustained Response in Older, Unfit Patients with Previously Untreated Chronic Lymphocytic Leukemia
Published: 2022-12-10 (Crawled : 16:20) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
imbruvica treatment glow leukemia response plus results study
TUT Fitness Group Expands Strategic Advisory Board
Published: 2022-11-10 (Crawled : 11:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
group
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
Published: 2022-11-03 (Crawled : 16:00) - prnewswire.com
GNMSF | News | $284.55 3.83% 240
|
Health Technology
|
| O: -2.44%
H: 5.65%
C: 5.65%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
GMAB | News | $28.97 0.94% 0.93% 450K
|
Health Technology
|
| O: -1.73%
H: 4.51%
C: 3.15%
U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease
Published: 2022-08-24 (Crawled : 00:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
imbruvica treatment fda disease
Global Sunless Tanners Market Trajectory & Analytics 2022-2026: Concerns over Skin Cancer Move UV-Free Tanners Demand in Upward Trajectory
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
UNLYF | $47.6 1.3% 270
|
Consumer Non-Durables
|
| O: 2.72%
H: 0.0%
C: -1.86%
UL | $48.06 1.59% 0.0% 3.1M
|
Consumer Non-Durables
|
| O: -0.07%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
EPC 4 | $36.84 0.52% 0.0% 200K
|
Consumer Non-Durables
|
| O: -0.24%
H: 2.88%
C: 2.58%
analytics skin cancer market
BioSpace Movers & Shakers: ADC, Akari, Scorpion & More
Published: 2022-06-17 (Crawled : 13:00) - biospace.com/
CMRA | $0.041 70.59% 2.4K
|
n/a
|
| O: -5.71%
H: 49.39%
C: 34.55%
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -4.49%
H: 0.0%
C: 0.0%
LZAGF | $548.0 -19.1% 160
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
LZAGY | $55.15 0.02% 49K
|
Professional, Scientific, and T...
|
| O: 0.58%
H: 1.5%
C: 0.83%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BSX | $68.02 1.03% 0.0% 7.6M
|
Health Technology
|
| O: 1.69%
H: 2.14%
C: 1.18%
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.